Christopher Aker - Jan 11, 2023 Form 4/A - Amendment Insider Report for Regulus Therapeutics Inc. (RGLS)

Role
Sr. VP & General Counsel
Signature
Christopher Aker
Stock symbol
RGLS
Transactions as of
Jan 11, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/17/2023, 03:13 PM
Date Of Original Report
Jan 17, 2023
Previous filing
May 11, 2022
Next filing
Aug 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGLS Stock Option (Right to Buy) Award $0 +45K $0.00 45K Jan 11, 2023 Common Stock 45K $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.